Correction to: Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies (Targeted Oncology, (2023), 18, 1, (9-24), 10.1007/s11523-022-00941-7)

Popat S.Ahn M.J.Ekman S.Leighl N.B.Ramalingam S.S.Reungwetwattana T.Siva S.Tsuboi M.Wu Y.L.Yang J.C.H.Mahidol University2023-05-192023-05-192023-03-01Targeted Oncology Vol.18 No.2 (2023) , 31117762596https://repository.li.mahidol.ac.th/handle/20.500.14594/81644While typesetting the articles the formatting of the Tables was incorrect. Now this has been corrected. The original article has been corrected.Biochemistry, Genetics and Molecular BiologyCorrection to: Osimertinib for EGFR-Mutant Non-Small-Cell Lung Cancer Central Nervous System Metastases: Current Evidence and Future Perspectives on Therapeutic Strategies (Targeted Oncology, (2023), 18, 1, (9-24), 10.1007/s11523-022-00941-7)ErratumSCOPUS10.1007/s11523-023-00947-92-s2.0-851476762591776260X36752975